These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28065729)

  • 1. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
    Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
    Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
    Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Ueda N; Tsuboi K; Uyama T
    Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
    Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
    FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
    Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
    Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
    Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
    J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of acid ceramidase in the degradation of bioactive N-acylethanolamines.
    Tsuboi K; Tai T; Yamashita R; Ali H; Watanabe T; Uyama T; Okamoto Y; Kitakaze K; Takenouchi Y; Go S; Rahman IAS; Houchi H; Tanaka T; Okamoto Y; Tokumura A; Matsuda J; Ueda N
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158972. PubMed ID: 34033896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Tsuboi K; Takezaki N; Ueda N
    Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon γ treatment increases endocannabinoid and related N-acylethanolamine levels in T84 human colon carcinoma cells.
    Alhouayek M; Rankin L; Gouveia-Figueira S; Fowler CJ
    Br J Pharmacol; 2019 May; 176(10):1470-1480. PubMed ID: 29313885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities.
    Bottemanne P; Muccioli GG; Alhouayek M
    Drug Discov Today; 2018 Aug; 23(8):1520-1529. PubMed ID: 29567427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of orthotopic implantation of rat prostate tumour cells upon components of the N-acylethanolamine and monoacylglycerol signalling systems: an mRNA study.
    Alhouayek M; Stafberg L; Karlsson J; Bergström SH; Fowler CJ
    Sci Rep; 2020 Apr; 10(1):6314. PubMed ID: 32286386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.
    Kaczocha M; Glaser ST; Chae J; Brown DA; Deutsch DG
    J Biol Chem; 2010 Jan; 285(4):2796-806. PubMed ID: 19926788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
    Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
    Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
    J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
    Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis.
    Petrosino S; Puigdemont A; Della Valle MF; Fusco M; Verde R; Allarà M; Aveta T; Orlando P; Di Marzo V
    Vet J; 2016 Jan; 207():85-91. PubMed ID: 26639824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
    Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
    Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
    J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
    Fowler CJ; Jonsson KO; Tiger G
    Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
    Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.